ClinConnect ClinConnect Logo
Search / Trial NCT06630962

Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care

Launched by NORTHWESTERN UNIVERSITY · Oct 4, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Financial Navigation Financing Cancer Care Nigeria Breast Neoplasm Prostate Neoplasm Colon Neoplasm Rectal Neoplasm Health Insurance Randomized Control Trial Healthcare Cost Health Expenditure Financial Risk Sharing Universal Health Insurance National Health Insurance Scheme Catastrophic Health Spending Financial Distress Sub Saharan Africa Health Plan Implementation Global Health Healthcare Economics And Organizations Clinical Oncology Cancer Care Facilities Surgical Oncology Global Burden Of Disease Social Determinants Of Health Health Impact Assessment

ClinConnect Summary

This clinical trial is studying how a special financial support program can help cancer patients in Nigeria manage the costs and stress that come with their treatment. The researchers want to find out if this program can significantly lower the financial burden and anxiety that patients feel. They are also looking into whether this financial navigation program is affordable and practical for cancer treatment centers in Nigeria.

To take part in the study, participants must be at least 18 years old and have recently been diagnosed with breast, prostate, or colorectal cancer, but they should not have started major treatments like chemotherapy or radiation yet. During the study, participants will fill out surveys about their personal and medical background, their quality of life, and any costs related to their cancer care. By comparing those who receive the financial support with those who do not, the researchers hope to learn more about the impact of financial help on cancer patients’ lives. The trial is currently recruiting participants, so if you or someone you know might be eligible, it could be a valuable opportunity to contribute to this important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 years and older
  • Recently diagnosed with breast, colorectal or prostate cancer within 6 weeks of presentation at the study site
  • Have not received definitive chemotherapy, radiotherapy, or undergone major surgery (diagnostic or temporary interventions, such as excisional biopsy or temporary colostomy may still enroll)
  • Candidate for definitive cancer treatment
  • Exclusion Criteria:
  • Unable to provide consent
  • Has initiated definitive cancer treatment at the study site or elsewhere in the past
  • Only receiving best supportive care

About Northwestern University

Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.

Locations

Ile Ife, , Nigeria

Lagos, , Nigeria

Patients applied

0 patients applied

Trial Officials

Juliet Lumati

Principal Investigator

Northwestern University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported